Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses.
about
Targeting C-Type Lectin Receptors for Cancer ImmunityScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyThe STING pathway and the T cell-inflamed tumor microenvironmentCard9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in mice.Immunosurveillance and immunotherapy of tumors by innate immune cells.Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma.The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis.Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.C-type lectins in immunity: recent developments.FAM26F: An Enigmatic Protein Having a Complex Role in the Immune System.Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.Type I Interferons and Natural Killer Cell Regulation in Cancer.Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.Pre-infection transcript levels of FAM26F in peripheral blood mononuclear cells inform about overall plasma viral load in acute and post-acute phase after simian immunodeficiency virus infection.Autocrine Type I IFN Signaling in Dendritic Cells Stimulated with Fungal β-Glucans or Lipopolysaccharide Promotes CD8 T Cell Activation.Gene expression changes in immune response pathways following oral administration of tetrabromobisphenol A (TBBPA) in female Wistar Han rats.Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden.How the immune system spots tumors.FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells.Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis.The Aryl Hydrocarbon Receptor and Tumor Immunity.C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets.Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases.Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia.Macrophage Heterogeneity in the Immunopathogenesis of Tuberculosis.Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation.Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer ProgressionNovel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways
P2860
Q26784483-6E1561A3-B211-434A-8E84-29599872FFC0Q26799114-5F33AC16-8A3C-405B-8D69-0AF01BC128FBQ27008371-AFDED24F-D2D1-4D50-9E27-3930B84C3EB0Q33697792-0EE7F88A-DF2A-4E7F-A8C6-CFEE649DCCA5Q36471212-DF08584F-66FA-40CE-88AF-C9B814CDE342Q37012718-C2FA1B85-F73D-43B5-AB03-0AE7554654A4Q37236780-5C8EB671-E1E2-4A44-B1B6-49AE529386CAQ37493320-3ECBC192-F030-4E55-A6E5-70EFAAFF88D8Q37536440-FE435E33-5988-495E-9719-8A7D1AB09C7CQ37558139-99140A6E-4C7D-475A-8A33-C0E53E5EE47DQ38305222-D383DEFE-E65C-42A7-B11A-264505FC310EQ38819729-568779D7-D96D-4E6C-B73B-430DB24062F6Q38844576-084DD522-FAB0-4C4B-A05F-B8E97A69E774Q39238946-BA545880-E80A-42CA-AE77-4A6C90066671Q39241784-DAD6E6F3-BC0A-4CA5-9B20-37B618A7BBE4Q39271596-73B9E15B-2768-4AEF-985B-B233C578F23BQ40430036-9A599E47-DDEF-4539-9B02-EAD3C2CCA303Q40441584-5CFF40B8-E4FC-40E0-B74A-F4300BC8AA1EQ40452707-F89ED07B-8044-4D77-99EB-1B5DF048C2F9Q40809801-2B6C5436-A67B-4CE6-B0C0-C2BB411433B7Q42029592-019FC693-BC7A-48B4-9CF3-8DF12E16A8EEQ45365480-3686187D-E54F-4EFC-911F-1D62855DD8C3Q46311213-38838D9B-9003-4BD7-B7ED-36F191CB1956Q50327400-F272E9EE-3504-4B05-BC87-33A5C923911EQ50351148-7A30011D-D61F-45CC-99B8-BC2FD2CF62BEQ52726750-2F2F9826-7A2A-4454-83E4-D483EE7C5A9BQ52730720-D6850355-EC0D-466C-8F75-22EEE7B64D13Q53110546-0F641DAB-8692-4656-A5FA-68FA21912A63Q55077165-4F685020-5998-4987-A2F3-C7C0AE9CA6B1Q55325579-76D932B7-35A5-402A-A642-282165A77B08Q58780996-4FA41103-F5FB-4F2A-9C80-99F7E2E5C3B4Q58804719-D009AD60-CD7A-4D8F-BE7E-68CE685D72BA
P2860
Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recognition of tumor cells by ...... ells for anti-tumor responses.
@ast
Recognition of tumor cells by ...... ells for anti-tumor responses.
@en
Recognition of tumor cells by ...... ells for anti-tumor responses.
@nl
type
label
Recognition of tumor cells by ...... ells for anti-tumor responses.
@ast
Recognition of tumor cells by ...... ells for anti-tumor responses.
@en
Recognition of tumor cells by ...... ells for anti-tumor responses.
@nl
prefLabel
Recognition of tumor cells by ...... ells for anti-tumor responses.
@ast
Recognition of tumor cells by ...... ells for anti-tumor responses.
@en
Recognition of tumor cells by ...... ells for anti-tumor responses.
@nl
P2093
P2860
P356
P1433
P1476
Recognition of tumor cells by ...... ells for anti-tumor responses.
@en
P2093
Hideo Negishi
Hideyuki Yanai
Hiroaki Ikushima
Hiroshi Ueki
Junko Nishio
Shiho Chiba
Shinobu Saijo
Sho Hangai
Tadatsugu Taniguchi
Tomohiko Tamura
P2860
P304
P356
10.7554/ELIFE.04177
P407
P577
2014-08-22T00:00:00Z